清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

医学 结直肠癌 全直肠系膜切除术 累积发病率 外科 放化疗 入射(几何) 临床终点 阶段(地层学) 随机对照试验 癌症 放射治疗 内科学 古生物学 物理 光学 生物 移植
作者
Rolf Sauer,Torsten Liersch,Susanne Merkel,Rainer Fietkau,Werner Hohenberger,Clemens F. Hess,Heinz Becker,Hans-Rudolf Raab,Marie-Therese Villanueva,Helmut Witzigmann,Christian Wittekind,Tim Beißbarth,Claus Rödel
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:30 (16): 1926-1933 被引量:2114
标识
DOI:10.1200/jco.2011.40.1836
摘要

PURPOSE: Preoperative chemoradiotherapy (CRT) has been established as standard treatment for locally advanced rectal cancer after first results of the CAO/ARO/AIO-94 [Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of the Germany Cancer Society] trial, published in 2004, showed an improved local control rate. However, after a median follow-up of 46 months, no survival benefit could be shown. Here, we report long-term results with a median follow-up of 134 months. PATIENTS AND METHODS: A total of 823 patients with stage II to III rectal cancer were randomly assigned to preoperative CRT with fluorouracil (FU), total mesorectal excision surgery, and adjuvant FU chemotherapy, or the same schedule of CRT used postoperatively. The study was designed to have 80% power to detect a difference of 10% in 5-year overall survival as the primary end point. Secondary end points included the cumulative incidence of local and distant relapses and disease-free survival. RESULTS: Of 799 eligible patients, 404 were randomly assigned to preoperative and 395 to postoperative CRT. According to intention-to-treat analysis, overall survival at 10 years was 59.6% in the preoperative arm and 59.9% in the postoperative arm (P = .85). The 10-year cumulative incidence of local relapse was 7.1% and 10.1% in the pre- and postoperative arms, respectively (P = .048). No significant differences were detected for 10-year cumulative incidence of distant metastases (29.8% and 29.6%; P = .9) and disease-free survival. CONCLUSION: There is a persisting significant improvement of pre- versus postoperative CRT on local control; however, there was no effect on overall survival. Integrating more effective systemic treatment into the multimodal therapy has been adopted in the CAO/ARO/AIO-04 trial to possibly reduce distant metastases and improve survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai的应助被科研通管家采纳,获得10
8秒前
Khan完成签到,获得积分10
9秒前
天天快乐的应助被Wang采纳,获得10
13秒前
公子小白完成签到,获得积分10
18秒前
迷路牛青完成签到,获得积分10
21秒前
limengyao完成签到,获得积分10
45秒前
温柔晓筠完成签到,获得积分10
46秒前
落后的雪青完成签到,获得积分10
1分钟前
Aman完成签到,获得积分10
1分钟前
精明开山完成签到,获得积分10
1分钟前
1分钟前
Wang发布了新的文献求助10
1分钟前
安静怜雪完成签到,获得积分10
1分钟前
火柴盒完成签到,获得积分10
1分钟前
隐形雅柔完成签到,获得积分10
1分钟前
dnpl完成签到,获得积分10
1分钟前
潇洒醉冬完成签到,获得积分10
1分钟前
Aman完成签到,获得积分10
1分钟前
Aman完成签到,获得积分10
1分钟前
细心的语蓉完成签到,获得积分10
1分钟前
车车完成签到 ,获得积分10
1分钟前
追寻的凌香完成签到,获得积分10
1分钟前
2分钟前
Maestro_S的应助被科研通管家采纳,获得10
2分钟前
调皮烤鸡完成签到,获得积分10
2分钟前
能干的孱完成签到,获得积分10
2分钟前
小巧的大凄完成签到,获得积分10
2分钟前
2分钟前
古炮完成签到 ,获得积分10
2分钟前
又何必呢完成签到 ,获得积分10
2分钟前
英俊的青烟完成签到,获得积分10
3分钟前
TingtingGZ发布了新的文献求助10
3分钟前
沉默怡完成签到,获得积分10
3分钟前
田田完成签到 ,获得积分10
3分钟前
奔跑的应助被武雨寒采纳,获得10
3分钟前
梁吃鱼完成签到 ,获得积分10
3分钟前
无悔完成签到 ,获得积分0
3分钟前
内向的小丸子完成签到,获得积分10
3分钟前
科研通AI65的应助被兰斯洛特117采纳,获得10
3分钟前
大力的美女完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173213
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780496
捐赠科研通 7767342
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555730
邀请新用户注册赠送积分活动 2476697